Lv7
3480 积分 2021-12-27 加入
Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
6天前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
6天前
已完结
HER2-targeted therapies beyond breast cancer — an update
6天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
12天前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
12天前
已完结
Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
15天前
已完结
Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape
15天前
已完结
Antibody-Drug Conjugates Against Multidrug-Resistant Cancers: Biomarker-Guided Patient Selection, Payload Engineering, Linker Chemistry, and Bystander Effects
15天前
已完结
Drug-induced interstitial lung disease
18天前
已完结
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
23天前
已完结
皖公网安备34019202002308
